FANAX
Price
$42.92
Change
-$1.14 (-2.59%)
Updated
Dec 18 closing price
IYEFX
Price
$8.65
Change
-$0.27 (-3.03%)
Updated
Dec 18 closing price
Ad is loading...

FANAX vs IYEFX

Header iconFANAX vs IYEFX Comparison
Open Charts FANAX vs IYEFXBanner chart's image
Fidelity Advisor Energy A
Price$42.92
Change-$1.14 (-2.59%)
VolumeN/A
CapitalizationN/A
Delaware Climate Solutions R
Price$8.65
Change-$0.27 (-3.03%)
VolumeN/A
CapitalizationN/A
FANAX vs IYEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FANAX vs. IYEFX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FANAX is a Sell and IYEFX is a Hold.

FUNDAMENTALS
Fundamentals
FANAX has more cash in the bank: 1.24B vs. IYEFX (113M). IYEFX pays higher dividends than FANAX: IYEFX (2.24) vs FANAX (1.79). FANAX was incepted earlier than IYEFX: FANAX (28 years) vs IYEFX (12 years). IYEFX is a more actively managed with annual turnover of: 108.00 vs. FANAX (21.00). FANAX (0) and IYEFX (0) have matching initial minimum investment requirements. FANAX annual gain was more profitable for investors over the last year : 3.23 vs. IYEFX (0.01). FANAX return over 5 years is better than : 75.75 vs. IYEFX (17.30).
FANAXIYEFXFANAX / IYEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years12 years-
Gain YTD3.233-1.846-175%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.24B113M1,099%
Annual Yield % from dividends1.792.2480%
Returns for 1 year3.230.0141,032%
Returns for 3 years75.7237.53202%
Returns for 5 years75.7517.30438%
Returns for 10 years38.19-31.66-121%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GMAB20.030.01
+0.05%
Genmab A/S ADS
ULBI7.76-0.06
-0.77%
Ultralife Corp
MTRN106.57-1.57
-1.45%
Materion Corp
CGEM11.49-0.31
-2.63%
Cullinan Therapeutics
CISS0.67-0.03
-3.74%
C3is